Publication
Development and evaluation of clinical models based on ultrasound, serum CA153 and molecular subtype in predicting the efficacy of neoadjuvant chemotherapy in breast cancer.
Ming-Yue Du, Shu-E Zeng
Oncology lettersOct 1, 2026PMID 42741650doi:10.3892/ol.2026.15841 PMC13573283Journal ArticlepubmedProvenance
- Source
- PubMed
- Retrieved
- Sep 29, 2026
- Layer
- normalized (units and labels harmonized; values unchanged)
- Run
- ING-PUBMED-20260929-000001
Abstract
Abstract (excerpt)
Only the opening of the abstract is shown; abstract text may carry publisher copyright.
Breast cancer is a threat to health, and reliable predictors for neoadjuvant chemotherapy (NAC) efficacy remain limited. The aim of the present study was to develop a clinical model that combines ultrasonography with clinical and pathological characteristics to predict the effectiveness of NAC in…
Read on PubMedLinked entities
Linked entities (1)
How each link was made (MeSH, dictionary, registry reference, curation…) and whether it has been validated. Candidate links are not counted in entity statistics.
Candidate 1
- cancerMalignant Breast Neoplasmdictionary0.60
Curated evidence
Evidence citing this paper (0)
Data not yet available
No curated evidence item cites this publication.